Fabrication of Anti-human Cardiac Troponin I Immunogold Nanorods for Sensing Acute Myocardial Damage
© to the authors 2009
Received: 1 July 2009
Accepted: 9 August 2009
Published: 21 August 2009
A facile, rapid, solution-phase method of detecting human cardiac troponin I for sensing myocardial damage has been described using gold nanorods-based biosensors. The sensing is demonstrated by the distinct change of the longitudinal surface plasmon resonance wavelength of the gold nanorods to specific antibody–antigen binding events. For a higher sensitivity, the aspect ratio of gold nanorods is increased up to ca 5.5 by simply adding small amount of HCl in seed-mediated growth solution. Experimental results show that the detecting limit of the present method is 10 ng/mL. Contrast tests reveal that these gold nanorods-based plasmonic biosensors hold much higher sensitivity than that of conventionally spherical gold nanoparticles.
KeywordsGold nanorod Biosensor Surface modification Cardiac troponin I
Cardiac troponin I (cTnI) is a protein subunit of cardiac troponin complex. During the myocardial damage process, the troponin complex is broken up, and the individual protein components including cTnI are released into the bloodstream . Early detection of cTnI in the serum of patients with a higher risk of acute myocardial infarction can decrease the danger of death from heart attack. Because of high tissue specificity that ensuring an accurate assay, cTnI has been considered as the “gold standard” of cardiac marker for clinic diagnosis of acute myocardial damage [2–4]. Currently, most cTnI detections are based on the traditional enzyme linked immunosorbent assay (ELISA) methods. For a typical ELISA process, a capture anti-cTnI antibody against cTnI is firstly immobilized onto the surface of plastic well, followed by adding a patient sample containing cTnI for binding the capture anti-cTnI antibody. Then an enzyme labeled detector anti-cTnI antibody is allowed to bind with the immobilized cTnI. In each step mentioned above, quite a few wash cycles are necessary in order to remove the unbound antibody or antigen from the well. Finally, enzymatic substrate is added, and cTnI is detected by an enzyme-dependent color-change reaction. The entire ELISA process can usually take several hours to days to accomplish, which is labor-intensive and time-consuming. To overcome these limitations, it is of significance to develop a convenient, rapid and homogeneous immunoassays strategy for detecting cTnI events.
In recent years, biomedical research has received a large advancement, which greatly benefit from the development of nanomaterials [5–7]. Among these nanomaterials, gold nanoparticles (NPs) hold unique optical properties called localized surface plasmon resonance (LSPR) arising from oscillation of the free electrons in the gold, good biosafety and facile surface modification, enabling them quite suitable nanoscale platforms for biosensing or antibody–antigen immunoassay . In general, the label-free sensing using gold NPs can be achieved by analyte-mediated gold NPs aggregation. This concept is that the surface of the gold NPs needs to be modified with recognition molecules that specifically bind the analyte of interest. The recognition molecules-modified gold NPs will be brought very close to each other by recognition molecule-target molecular conjugation after adding the analyte solution, which brings on the coupling of plasmon resonances from adjacent NPs. As a result, the SPR band(s) of aggregated gold NPs will be broadened and red-shifted as a function of the amount of analyte. These changes can be recorded on a conventional UV–visible spectrophotometer . As a face-centered cubic metal with intrinsically high symmetry, the most common and easily obtained shape of gold NPs is a spherical one. For this main reason, spherical gold NPs are involved in most of the exiting works utilizing gold NPs aggregation effects to sense specific target binding events so far. Recently, both experimental and computational studies have revealed that the shape of gold NPs plays a key role in determining their optical properties [8, 10–12]. In particular, gold NPs with elongated shape called nanorods (NRs) have attracted much attention, because their highly anisotropic shape exhibits specially optical properties that are much different from commonly spherical ones . For instance, gold NRs show two distinct LSPR bands owing to the transverse and the longitudinal oscillation of the electrons respectively, one at short wavelength about 510 nm and the other at long wavelength beyond 600 nm, whereas spherical gold NPs displays only one band around 520 nm. In terms of LSPR sensing, there are several advantages to gold NRs compared to spherical NPs. First of all, the longitudinal SPR band of gold NRs has a higher sensitivity to the changes of the local dielectric surroundings, including solvent, adsorbed molecules and the aggregate state, when compared to similar-sized spherical NPs [14–16]. Since the longitudinal and transverse LSPR bands of gold NRs are basically independent of each other, one can use the changes of the longitudinal SPR band for more sensitive detection of target molecules. Secondly, it is also observed that this sensitivity of longitudinal band increases with higher aspect ratio (length divided by width, denoted as AR), leading to an improved detection sensitivity [17, 18]. In addition, increasing the AR of gold NRs can easily tailor the longitudinal SPR band from the visible to the near infrared (NIR) region (700–1,000 nm), which is a transparent window for hemoglobin and facilitate the detection of whole blood samples . Thirdly, because spherical shape has the smallest surface area relative to objects of other shapes (when the volume is fixed), gold NRs give a much larger surface area compared with spherical ones for adsorption of protein. Thanks to the efforts of many research groups, gold NRs can be synthesized routinely with high monodispersity at present time, which is an essential factor for using gold NR as LSPR sensors.
In this letter, we describe a convenient and rapid method for human cTnI detection in solution using anti-human cTnI immunogold NRs. The sensing was based on changes of longitudinal LSPR band induced by specific anti-h-cTnI antibody-h-cTnI binding events. To our knowledge, it is the first report of taking advantage of gold NRs for sensing h-cTnI. In order to improve the sensitivity, gold NRs with a higher AR ca. 5.5 are fabricated successfully by adding small amount of HCl in the growth solution through a modified seed-mediated approach. The detection limit of the present method is 10 ng/mL, which exhibits much higher sensitivity of detecting h-cTnI events than that of spherical gold NPs.
Cetyltrimethylammonium bromide (CTAB, 99%, Cat No: H6269) and Poly(styrenesulfonate) (PSS, Mw 70,000) were purchased from Sigma. Hydrogen tetrachloroauric acid (HAuCl4·4H2O, 99%), hydrochloric acid (HCl), sliver nitrate, sodium borohydride (NaBH4, 96%) andl-ascorbic acid (AA) were all purchased from Shanghai Chemical Reagent Co. Ltd (China). Millipore-quality water (18.18 MΩ/cm) was used throughout the experiments. cTnI from human myocardium muscle and the monoclonal anti-human cTnI antibodies used in the experiment were obtained from Research Institute of Cardiovascular Disease of First Affiliated Hospital of Nanjing Medical University.
Fabrication of Monodisperse Gold NRs
Gold NRs were fabricated based on a seed mediated, CTAB-assisted growth procedure by Nikoobakht et al.  with some modifications. Gold seed solution was prepared first by adding 0.6 mL of ice-cold solution of 10 mM NaBH4 to 10 mL of 0.25 mM HAuCl4 prepared in 0.1 M CTAB solution, under vigorous stirring for 2 min. The yellow color changed immediately to brown, indicating the formation of gold seeds. These seeds were aged for 2 h in order to allow the hydrolysis of unreacted NaBH4,The growth procedure was scaled up to obtain a 100 mL dispersion of the gold NRs. Briefly, the solutions were added to a 250 mL conical flask, in the following order: 100 mL of 0.1 M CTAB solution, 1.0 mL of 10 mM silver nitrate solution, 2 mL of 25 mM aqueous HAuCl4 and 0.4 mL of 1 M HCl solution. To this was added 0.70 mL of 0.0788 M AA as reducing agent, and the mixture was homogenized by stirring gently. Finally, 120 μL of seed solution was added, and the whole solution was left undisturbed overnight (14–16 h).
Typically, 10 mL of as-fabricated gold NRs was centrifuged at 13,000 g/min for 20 min, the supernatant was discarded, and the precipitate was redispersed in 5 mL of Milli-Q water. Subsequently, it was added dropwise to 1 mL of PSS (2.5 mg/L,) aqueous solution under vigorous stirring. After adding PSS solution, the mixture was kept undisturbed for 0.5 h. Then, it was centrifuged twice at 12,500 g/min to remove excess polyelectrolyte and dispersed in 5 mL of Tris buffer (pH = 8.2).
Conjugation of Anti-h-cTnI Antibody with PSS-capped Gold NRs
The PSS-capped gold NRs were mixed with excess amount of anti-h-cTnI solution (50 μg/mL in Tris buffer) for 30 min under magnetic stirring. The mixture was centrifuged in order to remove unbinding antibodies and redispersed into Tris buffer. Finally, these antibody conjugated gold NRs were store at 4 °C for further utilization.
Binding of h-cTnI to Anti-h-cTnI Antibody Conjugated Gold NRs
In each experiment, 1.0 mL of anti-cTnI antibody conjugated gold NRs was added to a fixed amount (1, 10, 100, 200, 400, 500 ng) of h-cTnI under vortex mixing. The resultant mixture was incubated for 15 min before recording with 2802S (UNICO) spectrophotometer.
Transmission electron microscopy (TEM) images were taken with a JEM-2000EX (JEOL) transmission electron microscope operated at 120 kV. The samples were prepared by dropping the dispersion of gold products onto the carbon-coated copper grid and dried in ambience. UV–vis–NIR spectra were recorded on a 2802S (UNICO) spectrophotometer in the 300–1,100 nm range. Fourier transform infrared (FTIR) spectra were measured on a Magna FTIR-750 (Nicolet) spectrometer, and the vacuum-dried sample was made in the form of a KBr pellet.
Results and Discussion
Fabrication, Surface Functionalization and Characterization of Gold NRs
Detection of h-cTnI Using Anti-h-cTnI Antibody Conjugated Gold NRs in Solution
In summary, we have described here a rapid and sensitive method of detecting human cTnI for sensing myocardial damage. This method is based on the changes of longitudinal SPR band of gold NRs induced by the anti-h-cTnI antibody-h-cTnI recognition events. For purpose of improving the detect sensitivity, the average AR of gold NRs is adjusted to 5.5 by adding a proper amount of HCl to the seed-mediated growth solution. The detection limit of the present method is 10 ng/mL. Contrast tests reveal clearly that these gold NRs-based biosensors are more sensitive for detecting cTnI events compared with that of spherical gold NPs. We are currently conducting studies for multiplex detection of the biomarkers of coronary syndrome by utilizing the AR dependence of the longitudinal LSPR wavelength of gold NRs.
R. Gu is the co-first author.
The authors gratefully acknowledge the support of the Medical Key Talent of Jiangsu Province (RC2007037) and the High-technology Platform of Jiangsu Province for Molecular Diagnosis and Biological Therapy of Critical Illness (XK200705). Dr. X. Z. Zhang would be greatly appreciated for technique assistance.
- Fishbein MC, Wang T, Matijasevic M, Hong LS, Apple FS: Cardiovasc. Pathol.. 2003, 12: 65. COI number [1:CAS:528:DC%2BD3sXislent7o%3D] 10.1016/S1054-8807(02)00188-6View Article
- Layrtza OF, Nayer H, Bill MJ, Sokoll LJ: Clin. Chim. Acta. 2003, 337: 173. 10.1016/j.cccn.2003.08.003View Article
- Zimmet H: Heart Lung Circ.. 2003, 12: S90. 10.1046/j.1443-9506.2003.00241.xView Article
- J. Am. Coll. Cardiol.. 2000, 36: 959. 10.1016/S0735-1097(00)00804-4
- Yang H, Xia Y: Adv. Mater.. 2007, 19: 3085. COI number [1:CAS:528:DC%2BD2sXht12jt7zN] 10.1002/adma.200702050View Article
- Wang X, Yang L, Chen Z, Shin DM: CA Cancer J. Clin.. 2008, 58: 97. 10.3322/CA.2007.0003View Article
- De M, Ghosh PS, Rotello VM: Adv. Mater.. 2008, 20: 1. 10.1002/adma.200703183View Article
- Hu M, Chen J, Li Z, Au L, Hartland GV, Li X, Marqueze M, Xia Y: Chem. Soc. Rev.. 2006, 35: 1084. COI number [1:CAS:528:DC%2BD28XhtFSgtL%2FK] 10.1039/b517615hView Article
- Rosi NL, Mirkin CA: Chem. Rev.. 2005, 105: 1547. COI number [1:CAS:528:DC%2BD2MXisVymsLk%3D] 10.1021/cr030067fView Article
- Liz-Marzán LM: Langmuir. 2006, 22: 32. 10.1021/la0513353View Article
- Orendorff CJ, Sau TK, Murphy CJ: Small. 2006, 2: 636. COI number [1:CAS:528:DC%2BD28XjsFCit70%3D] 10.1002/smll.200500299View Article
- Noguez C: J. Phys. Chem. C. 2007, 111: 3806. COI number [1:CAS:528:DC%2BD2sXhsFSit7Y%3D] 10.1021/jp066539mView Article
- Murphy CJ, Gole AM, Hunyadi SE, Orendorff CJ: Inorg. Chem.. 2006, 45: 7544. COI number [1:CAS:528:DC%2BD28Xpt1ektbk%3D] 10.1021/ic0519382View Article
- McFarland AD, Van Duyne RP: Nano Lett.. 2003, 3: 1057. COI number [1:CAS:528:DC%2BD3sXlt1ygtro%3D]; Bibcode number [2003NanoL...3.1057M] 10.1021/nl034372sView Article
- Chen H, Kou X, Yang Z, Ni W, Wang J: Langmuir. 2008, 24: 5233. COI number [1:CAS:528:DC%2BD1cXltVyjs7c%3D] 10.1021/la800305jView Article
- Wang CG, Chen Y, Wang TT, Ma ZF, Su ZM: Chem. Mater.. 2007, 19: 5809. COI number [1:CAS:528:DC%2BD2sXhtF2jtbrL] 10.1021/cm0700899View Article
- Lee KS, El-Sayed MA: J. Phys. Chem. B. 2006, 110: 19220. COI number [1:CAS:528:DC%2BD28XptFahs7w%3D] 10.1021/jp062536yView Article
- Chen CD, Cheng SF, Chau LK, Wang CRC: Biosens. Bioelectron.. 2007, 22: 926. COI number [1:CAS:528:DC%2BD28Xhtlalsb3L] 10.1016/j.bios.2006.03.021View Article
- Jain PK, El-Sayed IH, El-Sayed MA: Nano Today. 2007, 2: 18. 10.1016/S1748-0132(07)70016-6View Article
- Nikoobakht B, El-Sayed MA: Chem. Mater.. 2003, 15: 1957. COI number [1:CAS:528:DC%2BD3sXivFGgu7w%3D] 10.1021/cm020732lView Article
- D.K. Smith, N.R. Miller, B.A. Korgel, doi: 10.1021/la900757s (2009)
- Murphy CJ, Sau TK, Gole AM, Orendorf CJ, Gao J, Gou L, Hunyadi SE, Li T: J. Phys. Chem. B. 2005, 109: 13857. COI number [1:CAS:528:DC%2BD2MXltlGgu7o%3D] 10.1021/jp0516846View Article
- Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD: Small. 2005, 1: 325. COI number [1:CAS:528:DC%2BD2MXhsVaiu74%3D] 10.1002/smll.200400093View Article
- Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou J, Chen H, Huo Q: J. Am. Chem. Soc.. 2008, 130: 2780. COI number [1:CAS:528:DC%2BD1cXhsF2rtbc%3D] 10.1021/ja711298bView Article
- Caruso F, Niikura K, Furlong DN, Okahata Y: Langmuir. 1997, 13: 3427. COI number [1:CAS:528:DyaK2sXjslajtbo%3D] 10.1021/la9608223View Article
- Ai H, Fang M, Jones SA, Lvov YM: Biomacromolecules. 2002, 3: 560. COI number [1:CAS:528:DC%2BD38XhsFWrsbs%3D] 10.1021/bm015659rView Article